# clm_584F4235D169

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 3,098,900,000 United States dollar  
valid_from: 2021-06-30  
valid_to: 2021-09-30  
published: 2021-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0F99CB02E0F4  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: 3,098,900,000 United States dollar", as of 2021-06-30 (until 2021-09-30). Claim clm_584F4235D169, https://asof.is/claim/clm_584F4235D169, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422021000025/0001804220-21-000025-index.htm (primary, SEC EDGAR 10-Q Q2 FY2021, published 2021-08-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,115,200,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_584F4235D169](/claim/clm_584F4235D169.md) | [clm_C9912D8698CC](/claim/clm_C9912D8698CC.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.